Here, we present the clinical characteristics of a patient with POMC deficiency due to a mutation in the POMC gene, hoping to contribute to a better understanding of the leptin-melanocortin pathway and to introduce possible treatment options. This evidence concerns the gene LEP and hyperinsulinemic hypoglycemia, familial, 4.